Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2018 Aug;11(8):1084–1093. doi: 10.1016/j.jcmg.2018.06.005

Figure-1. Kaplan-Meier Survival Plots for HF-free survival for patients with breast cancer by incorporating trastuzumab use as a time-dependent variable.

Figure-1.

(A.) Stratified by trastuzumab use. (B.) Stratified by trastuzumab and anthracycline use. AT, anthracycline and trastuzumab; A_noT, anthracycline and no trastuzumab; T_noA, trastuzumab and no anthracycline; and noAT, no anthracycline or trastuzumab